Two ASX shares, Pro Medicus Limited and Washington H. Soul Pattinson & Company Ltd, are catching the eye of investors with their recent performances and distinct market positions. Here’s a closer look at why these ASX value shares might be worth considering for an investment watchlist.
Pro Medicus Limited (ASX:PME)
Pro Medicus Limited, established in 1983, has seen a remarkable 53.5% increase in its share price since the beginning of 2024. The company specializes in radiology IT software that serves hospitals, imaging centers, and healthcare groups globally. Its product suite includes radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualization solutions.
One of Pro Medicus’ standout offerings is its flagship Visage software. This advanced tool enables radiologists to view large medical image files remotely via mobile devices, facilitating timely diagnostic decisions and potentially improving patient outcomes. The ability to access and interpret imaging data on-the-go aligns with the growing demand for remote and efficient healthcare solutions.
Washington H. Soul Pattinson & Company Ltd (ASX:SOL)
Washington H. Soul Pattinson & Company Ltd, founded in 1903, is another notable ASX player. This diversified investment company has a broad portfolio spanning various industries and asset classes. Among its significant holdings are stakes in TPG Telecom (ASX:TPG), New Hope Group (ASX:NHC), and a cross-shareholding in Brickworks (ASX:BKW).
The company’s strategy focuses on delivering superior returns through capital growth and steadily increasing dividends. With a history of never missing a dividend payment since its listing, Washington H. Soul Pattinson has established itself as a reliable and family-run investment company. It remains just 4.1% below its 52-week high, reflecting strong investor confidence.
PME Share Price Valuation
For those assessing Pro Medicus Limited, one valuation approach involves looking at its price-to-sales ratio. Currently, PME shares have a price-to-sales ratio of 95.59x, compared to a 5-year average of 85.76x. This suggests that the shares are trading above their historical average. However, this is only one of many factors to consider when evaluating a company's value. Context and comprehensive analysis are crucial for making informed investment decisions.
Both Pro Medicus Limited and Washington H. Soul Pattinson & Company Ltd have demonstrated strong performances and possess unique attributes that make them notable candidates for any ASX investment watchlist.